GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Debt-to-Revenue

BioRegenx (BioRegenx) Debt-to-Revenue : 0.81 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is BioRegenx Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

BioRegenx's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.84 Mil. BioRegenx's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.15 Mil. BioRegenx's annualized Revenue for the quarter that ended in Mar. 2024 was $2.47 Mil. BioRegenx's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.81.


BioRegenx Debt-to-Revenue Historical Data

The historical data trend for BioRegenx's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Debt-to-Revenue Chart

BioRegenx Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A 0.41 1.01 5.74 10.23

BioRegenx Quarterly Data
Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 6.66 13.38 11.25 0.81

Competitive Comparison of BioRegenx's Debt-to-Revenue

For the Health Information Services subindustry, BioRegenx's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioRegenx's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioRegenx's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioRegenx's Debt-to-Revenue falls into.



BioRegenx Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

BioRegenx's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.225 + 0) / 0.022
=10.23

BioRegenx's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.842 + 0.15) / 2.472
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


BioRegenx Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioRegenx's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRegenx (BioRegenx) Business Description

Traded in Other Exchanges
N/A
Address
5051 Peachtree Corners Circle, No. 200, Peachtree Corners, GA, USA, 30092
Findit Inc owns Findit.com and the Findit App. Findit.com and the Findit App operate as a Social Media Content Management Platform, that includes its own search engine. Members can utilize Findit search to submit URLs they want Findit to index in Findit search results. Nonmembers can come to Findit and enter search queries, Findit returns matching search results from content posted in Findit along with outside web pages that have been submitted.

BioRegenx (BioRegenx) Headlines

From GuruFocus